Blogs

Quality by Design: A Regulatory Initiative No More?

Can a Cannabis-based Drug Gain Approval in the U.S.?

View from Academia: "Scale Is Not Going to Do It" for Pharma's Future

An Indictment of Scientists: The Drug Development Challenge is Productivity, Not Funding

Pfizer's Wicks: “We are beginning to move into the unsustainable cycle."

Cancer Drugs: Are Manufacturers Still Dedicated to "Finding a Cure"?

Is Swine Flu Vaccine Development Schedule "Immutable"?